Rosalind Advisors, Inc. Q4 2025 Filing

Filed February 12, 2026

Portfolio Value

$284.5M

Holdings

42

Report Date

Q4 2025

Filing Type

13F-HR

All Holdings (42 positions)

#StockSharesValue% PortfolioType
1
DCTHDELCATH SYSTEMS, INC.
3,300,389$33.0M11.60%
2
YB4PSAVARA INC
3,403,721$20.5M7.21%
3
FRXFENNEC PHARMACEUTICALS INC
2,613,508$20.1M7.07%
4
XERSXERIS BIOPHARMA HOLDGS INC
2,111,700$16.6M5.83%
5
VRDNVIRIDIAN THERAPEUTICS INC
450,000$14.0M4.92%
6
MDWDMEDIWOUND LTD
749,054$13.8M4.86%
7
VSTMVERASTEM INC
1,788,475$13.8M4.85%
8
REPLREPLIMUNE GROUP INC
1,410,497$13.7M4.82%
9
ATYRASTRIA THERAPEUTICS INC
1,039,080$13.6M4.78%
10
HELPCYBIN INC
1,657,540$13.6M4.77%
11
EYPTEYEPOINT PHARMACEUTICALS INC
690,000$12.6M4.43%
12
CGONCG ONCOLOGY INC
300,000$12.5M4.38%
13
CYTKCYTOKINETICS INC
195,045$12.4M4.36%
14
XFORX4 PHARMACEUTICALS INC
2,605,920$10.4M3.66%
15
BRD1EURMIND MEDICINE MINDMED INC
750,000$10.0M3.53%
16
PRNPROFOUND MEDICAL CORP
1,068,955$8.4M2.96%
17
NSPRINSPIREMD INC
3,905,743$7.0M2.44%
18
OCULOcular Therapeutix, Inc
400,000$4.9M1.71%
19
AVBPARRIVENT BIOPHARMA INC
215,871$4.3M1.53%
20
TLPHTALPHERA INC
3,579,273$4.1M1.43%
21
MYOMYOMO INC
3,839,772$3.5M1.23%
22
QQQINVESCO QQQ TR
450,000$3.0M1.06%Put
23
PYPDPOLYPID LTD
696,556$3.0M1.06%
24
OKURONKURE THERAPEUTICS INC
730,488$2.1M0.74%
25
SPYSPDR S&P 500 ETF TR
510,000$1.9M0.66%Put
26
AVXLANAVEX LIFE SCIENCES CORP
1,168,600$1.9M0.66%Put
27
RGNTREGENTIS BIOMATERIALS LTD
251,510$1.7M0.60%
28
LVLNSPDR SERIES TRUST
1,937,600$1.3M0.47%Put
29
TRVITREVI THERAPEUTICS INC
100,000$1.3M0.44%
30
AQLTISHARES TR
200,000$1.1M0.39%Put
31
KURAKURA ONCOLOGY INC
100,000$1.0M0.37%
32
NRXSNEURAXIS INC
286,138$1.0M0.37%
33
GUTSFRACTYL HEALTH INC
385,731$848K0.30%
34
BFRIBIOFRONTERA INC
1,140,764$650K0.23%
35
AVBPARRIVENT BIOPHARMA INC
107,900$539K0.19%Call
36
VSTMVERASTEM INC
268,600$159K0.06%Call
37
QUREUNIQURE NV
100,000$95K0.03%Call
38
REPLREPLIMUNE GROUP INC
230,900$11K0.00%Call
39
VKTXVIKING THERAPEUTICS INC
100,000$2K0.00%Call
40
REPLREPLIMUNE GROUP INC
264,700$00.00%Put
41
RZLTREZOLUTE INC
263,100$00.00%Call
42
VTGNVISTAGEN THERAPEUTICS INC
493,400$00.00%Call